This study was part of a larger study on long term outcomes of vestibular schwannoma management. Vestibular schwannoma is a benign intracranial tumor, causing symptoms such as hearing loss, tinnitus, and balance problems due to pressure on adjacent structures. A small majority of these tumors is non-progressive and in these cases active surveillance is usually the management option of choice. In progressive tumors, surgery or radiotherapy is performed to prevent future complications such as brain stem compression or elevated intracranial pressure. After active intervention, active surveillance ensues in these patients too as they are followed-up for prolonged periods of time in order to identify possible recurrences.
Patients who participated in a survey study in 2014 were re-approached for participation in a survey in 2020 [10]. All patients were diagnosed with unilateral VS between 2003–2014. Patients with bilateral VS, other skull base pathologies or insufficient proficiency in the Dutch language to complete the questionnaires were excluded.
Several PRO measurements which are also used in today’s routine care were collected in this study. Patients received a general health-related quality of life (HRQL) questionnaire, the short form 36 (SF-36), and a disease-specific HRQL questionnaire, the Penn Acoustic Neuroma Quality-of-Life Scale (PANQOL)[11, 12]. In addition, patients were asked to complete the dizziness handicap inventory (DHI), the medical outcome study cognitive functioning scale (MOS-CFS), the decision regret scale and the productivity costs questionnaires (iPCQ)[13–15]. Combined, patients were asked to answer 117 questions.
Three different delivery methods were used: email, regular mail, and a hybrid of the two. Patients in the email group received an email invitation with a link to a digital informed consent form. After providing consent, patients were directed to digital questionnaires. Patients in the hybrid group were invited by regular mail with a letter including a unique code and a link to the digital informed consent form and the questionnaires. The regular mail group received an informed consent form, the printed questionnaires, and a stamped return envelope. After two weeks, patients received a first personally addressed reminder by email (email group) or mail (hybrid and regular mail group). After another two weeks, all non-responders were called once by phone for a second reminder. This phone call was performed by a researcher, not their treating physician. In all groups, patients could request a different delivery method.
Before introducing the electronic patient records in our hospital (in 2011), the patient’s email address was not registered. Therefore, an email address was available in a minority of the patients, making randomization impossible. Patients for whom the email address was registered were assigned to the email group. The patients in the other groups (regular mail and hybrid) were randomly assigned to one of these two delivery modes and matched with the patients in the email group for age and time since the last visit.
Descriptive statistics were used to calculate the frequencies of categorical variables. Because patients could switch delivery method, both an intention to treat and an as treated analysis were performed. The former analyzes the predefined delivery methods and the latter the actual delivery method, i.e., taking the patients who switched between delivery method into account. The outcome was the response rate per group, which was analyzed using a chi-squared test. We also assessed the effect of the second phone call reminder by a chi-squared test. In addition, the effect on the response rate of age, educational level, time elapsed since the last visit (in years), and the delivery method were analyzed using logistic regression with response rate as the dependent variable. The independent variables were selected based on their reported effect on response rates in previous literature [4, 8, 16]. Model assumptions for multicollinearity were checked by calculating the variance inflation factor (VIF) and goodness of fit was verified with a Hosmer Lemeshow test and model chi-squared test. A minimum sample size of 387 was required based on a power calculation for the primary outcome, which used the difference in response rates in previous research (effect size w = 0.2, α = 0.05, 1-β = 0.95).
All statistical analyses were performed in SPSS version 26 (Armonk, NY: IBM Corp). A p-value < 0.05 was considered as statistically significant. There were no missing data.